Loading…
Hepatocyte SHP-1 is a Critical Modulator of Inflammation During Endotoxemia
Liver hepatocytes (Hep) are known to be central players during the inflammatory response to systemic infection. Interestingly, the protein tyrosine phosphatases (PTP) SHP-1, has been recognized as a major regulator of inflammation; however their implication in the control of Hep-mediated inflammator...
Saved in:
Published in: | Scientific reports 2017-05, Vol.7 (1), p.2218-10, Article 2218 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Liver hepatocytes (Hep) are known to be central players during the inflammatory response to systemic infection. Interestingly, the protein tyrosine phosphatases (PTP) SHP-1, has been recognized as a major regulator of inflammation; however their implication in the control of Hep-mediated inflammatory response is still unknown. To study its implication in the regulation of the Hep-mediated inflammatory response during endotoxemia, Cre-Lox mice with a Hep-specific
Ptpn6
deletion (
Ptpn6
H-KO
) were injected with LPS. In contrast to the wild-type mice (
Ptpn6
f/f
) that started to die by 24 hrs post-inoculation, the
Ptpn6
H-KO
mice exhibited mortality by 6 hrs. In parallel, higher amounts of metabolic markers, pro-inflammatory mediators and circulating cytokines were detected in
Ptpn6
H-KO
mice. Primary Hep obtained from
Ptpn6
H-KO
, also showed increased secretion of pro-inflammatory cytokines and nitric oxide (NO) comparatively to its wild type (
Ptpn6
f/f
) counterpart. Pharmacological approaches to block TNF-α and NO production protected both the
Ptpn6
f/f
and the
Ptpn6
H-KO
mice against deadly LPS-mediated endotoxemia. Collectively, these results establish hepatocyte SHP-1 is a critical player regulating systemic inflammation. Our findings further suggest that SHP-1 activation could represent a new therapeutic avenue to better control inflammatory-related pathologies. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-02512-7 |